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Background
AKS a frequent AIDS tumor is associated with HHV8, but
is controversial whether clonal with recurrent genomic
changes or mostly reactive proliferation.
Materials and methods
KS biopsies were compared by IFA for LANA, CD34, Ki67,
lymphatic endothelial (LEC) marker (LYVE-1) and DNA
damage markers (Chk2). After microdissection DNA was
also analyzed by CGH for cytogenetic changes.
Results
LANA+ cells varied with frequency of CD34+ cells at all
stages of KS. However about 25% of CD34+ cells were
LANA- and LYVE-1-. All LANA+ SC were LYVE-1+, but
only 75% were CD34+. About 18% of LANA+ SC in early
KS were CD34- but LYVE-1+. This LANA+/LYVE-1+/
CD34- (resident LEC) cell's decreased from early to late
KS. Ki67+ cells were moderate (4.5–11.5%) at all KS
stages, but usually higher in early KS. CGH showed Y
chrom. deletion in most KS and was the only aberration
in early KS, whereas late KS also showed deletions of
chrom. 16 and 17, confirmed by FISH. Chk2 which is
upregulated at early stage of DNA damage was more fre-
quent in early than late KS.
Conclusion
The presence of CD34+/LANA- cells suggests a continuous
recruitment of non infected cells. Some LANA+ cells were
CD34-, but LYVE-1+ indicating that resident LEC's are tar-
geted by HHV-8 and transformed to SC. The Y deletion
and upregulation of Chk2 in early KS indicates genomic
instability from early stage of KS.
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